中华肝胆外科杂志
中華肝膽外科雜誌
중화간담외과잡지
CHINESE JOURNAL OF HEPATOBILIARY SURGERY
2015年
3期
165-169
,共5页
韩玮%王磊%徐永波%赵建华%菅凤国%张卫华%王涛%褚海波
韓瑋%王磊%徐永波%趙建華%菅鳳國%張衛華%王濤%褚海波
한위%왕뢰%서영파%조건화%관봉국%장위화%왕도%저해파
门静脉高压%脾肿大%脾大部切除术%分流术
門靜脈高壓%脾腫大%脾大部切除術%分流術
문정맥고압%비종대%비대부절제술%분류술
Portal hypertension%Splenomegaly%Subtotal splenectomy%Shunt
目的 分析肝炎后肝硬化门静脉高压症患者术后随访指标,评价脾大部切除大网膜胸骨后固定术治疗门静脉高压症的远期疗效.方法 回顾性分析1999年至2014年采用脾大部切除大网膜胸骨后固定术治疗肝硬化门静脉高压症的65例患者手术后生存率、再出血率及辅助检查指标的变化.结果 患者4年内死亡4例,4年生存率为94%,11年生存率为60%.术后食管胃底静脉曲张再出血11例(17%).术后6年和11年白细胞和血小板较术前明显升高(P<0.05);门静脉直径、门静脉血流量、脾动脉血流量较术前明显缩小或下降(P<0.05);脾脏长径、厚度、横截面积较术前明显缩小(P<0.05).血清巨噬细胞集落刺激因子(M-CSF)、粒细胞集落刺激因子(GM-CSF)水平较术前明显降低(P<0.05);CD3+T细胞、CD4+T细胞、CD8+T细胞百分比较术前明显升高(P<0.05);IgA、IgM、IgG、Tuftsin水平与术前比较无变化(P>0.05).15例术后数字减影血管造影(DSA)显示门上腔静脉侧支循环形成.结论 脾大部切除大网膜胸骨后固定术可有效控制肝硬化门静脉高压症患者的出血,纠正脾亢,并保留脾免疫功能,部分患者长期生存.
目的 分析肝炎後肝硬化門靜脈高壓癥患者術後隨訪指標,評價脾大部切除大網膜胸骨後固定術治療門靜脈高壓癥的遠期療效.方法 迴顧性分析1999年至2014年採用脾大部切除大網膜胸骨後固定術治療肝硬化門靜脈高壓癥的65例患者手術後生存率、再齣血率及輔助檢查指標的變化.結果 患者4年內死亡4例,4年生存率為94%,11年生存率為60%.術後食管胃底靜脈麯張再齣血11例(17%).術後6年和11年白細胞和血小闆較術前明顯升高(P<0.05);門靜脈直徑、門靜脈血流量、脾動脈血流量較術前明顯縮小或下降(P<0.05);脾髒長徑、厚度、橫截麵積較術前明顯縮小(P<0.05).血清巨噬細胞集落刺激因子(M-CSF)、粒細胞集落刺激因子(GM-CSF)水平較術前明顯降低(P<0.05);CD3+T細胞、CD4+T細胞、CD8+T細胞百分比較術前明顯升高(P<0.05);IgA、IgM、IgG、Tuftsin水平與術前比較無變化(P>0.05).15例術後數字減影血管造影(DSA)顯示門上腔靜脈側支循環形成.結論 脾大部切除大網膜胸骨後固定術可有效控製肝硬化門靜脈高壓癥患者的齣血,糾正脾亢,併保留脾免疫功能,部分患者長期生存.
목적 분석간염후간경화문정맥고압증환자술후수방지표,평개비대부절제대망막흉골후고정술치료문정맥고압증적원기료효.방법 회고성분석1999년지2014년채용비대부절제대망막흉골후고정술치료간경화문정맥고압증적65례환자수술후생존솔、재출혈솔급보조검사지표적변화.결과 환자4년내사망4례,4년생존솔위94%,11년생존솔위60%.술후식관위저정맥곡장재출혈11례(17%).술후6년화11년백세포화혈소판교술전명현승고(P<0.05);문정맥직경、문정맥혈류량、비동맥혈류량교술전명현축소혹하강(P<0.05);비장장경、후도、횡절면적교술전명현축소(P<0.05).혈청거서세포집락자격인자(M-CSF)、립세포집락자격인자(GM-CSF)수평교술전명현강저(P<0.05);CD3+T세포、CD4+T세포、CD8+T세포백분비교술전명현승고(P<0.05);IgA、IgM、IgG、Tuftsin수평여술전비교무변화(P>0.05).15례술후수자감영혈관조영(DSA)현시문상강정맥측지순배형성.결론 비대부절제대망막흉골후고정술가유효공제간경화문정맥고압증환자적출혈,규정비항,병보류비면역공능,부분환자장기생존.
Objective To analyze the important factors for follow-up in postoperative patients with portal hypertension (PHT) due to post-hepatitis cirrhosis,and to evaluate the long-term efficacy of subtotal splenectomy plus retrosternal fixation of greater omentum to treat PHT.Methods The post-operative survival rate,rebleeding rate and auxiliary examination indices of 65 patients,who were treated by subtotal splenectomy plus retrosternal fixation of the greater omentum for PHT between 1999 and 2014 were reviewed retrospectively.Results Four patients died within 4 years of surgery,with a 4-year survival rate of 94%,the 11-year survival rate was 60%.Eleven patients (17%) developed rebleeding from esophagogastric varices.The white blood cell and platelet counts were higher 6 and 11 years postoperatively when compared with the pre-operative values (P < 0.05).Portal venous diameter,portal venous flow volume,.splenic artery flow volume,as well as splenic length,thickness,and average cross-sectional areas were significantly constricted or decreased (P < 0.05).The proportions of serum CD3 + T cells,CD4 + T cells,and CD8 + T cells increased (P < 0.05),while the serum levels of macrophage colony-stimulating factor and granulocyte colonystimulating factor were significantly decreased (P < 0.05).There was no significant change in the serum levels of IgA,IgM,IgG,and Tuftsin (P >0.05).DSA demonstrated that in 15 patients collateral circulations formed between the portal vein and the superior vena cava.Conclusions Subtotal splenectomy plus retrosternal fixation of the greater omentum provided longterm results in prevent bleeding from esophagogastric variceal bleeding in patients with PHT.The operation corrected hypersplenism,and preserved splenic immune function.Longterm survival is expected in some patients with PHT.